Skip to main content
SpringerLink
Log in

Neuroendocrine effects of quipazine in man in health state or with neurological disorders

  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary

The endocrinological actions of quipazine, a direct serotonin receptor agonist, were investigated in both normal subjects (NS) and individuals with neurological disorders,i.e., Huntington's disease (HD), myoclonic epilepsy (ME) and cluster headache (CH). In both normal subjects and neurologic patients inconsistent and variable changes in the secretion of anterior pituitary hormones were observed. In fact, oral administration of 50 mg of quipazine elicited a rise in plasma GH in only 9/23 subjects investigated (3 NS, 2 HD, 1 ME, 3 CH), decreased GH in 4 subjects (1 NS, 2 HD, 1 CH) and left unmodified plasma GH in the remaining 10 subjects. Only 7/23 subjects showed a positive PRL response to quipazine (2 NS, 1 HD, 1 ME, 3 CH), in one subject (CH) PRL was inhibited while the drug was ineffective in the remaining 15 subjects. For gonadotropins, 5/21 subjects (2 NS, 1 HD, 2 CH) had a positive LH response and 3/20 subjects (1 NS, 1 ME, 1 CH) had a positive FSH response. In one subject (HD) there was inhibition of baseline LH levels and no effects were present in the remaining individuals. No changes in basal TSH levels were present in the 6 subjects investigated (4 NS, 2 ME). Quipazine was instead competent to increase plasma cortisol levels in 6/8 normal subjects. Pharmacodynamic, mainly gastrointestinal, effects of the drug were present in about 50% of the subjects but were not or only poorly correlated with the endocrine responses. Collectively, based on the neuropharmacologic profile of the drug, and in contrast to many animal data, these findings do not support a major role for the serotoninergic system on basal anterior pituitary hormone secretion in man, possibly with the exception of the ACTH-cortisol secretion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Anthony, M., Lance, J. W., Lord, G.: Migrainous-neuralgia. Blood histamine levels and clinical response to H1 and H2 receptor blockade. In: Current Concepts in Migraine Research (Greene, R., ed.), pp. 149–151. Academic Press. 1978.

  • Baum, C. K., Tudor, R., Landon, J. A simple competitive protein binding assay for plasma cortisol. Clinica Chim. Acta55, 147–154 (1974).

    Google Scholar 

  • Beck-Peccoz, P., Ferrari, C., Rondena, M., Paracchi, A., Faglia, G. Failure of oral 5-hydroxytryptophan administration to affect prolactin secretion in man. Hormone Res.7, 303–307 (1976).

    Google Scholar 

  • Benkert, O., Laakman, G., Souvatzoglou, A., von Werder, K. Missing indicator function of growth hormone and luteinizing hormone blood levels for dopamine and serotonin concentrations in the human. J. Neural Transm.34, 291–299 (1973).

    Google Scholar 

  • Berger, P. A., Barchas, J. D., Vernikos-Danellis, J. Serotonin and pituitaryadrenal function. Nature (Lond.)248, 242–246 (1974).

    Google Scholar 

  • Brambilla, F., Smeraldi, E., Sacchetti, E., Negri, F., Cocchi, D., Müller, E. E. Deranged anterior pituitary responsiveness to hypothalamic hormones in depressed patients. Arch. Gen. Psychiat.35, 1231–1238 (1978).

    Google Scholar 

  • Brodie, H. K. H., Sack, R., Siever, L. Serotonin and Behavior (Barcbas, J., Usdin, E., eds.), pp. 549–562. New York: Academic Press. 1973.

    Google Scholar 

  • Bruyn, G. W.: The biochemical basis of migraine: a critique. In: Clinical Neuropharmacology, Vol. 1 (Klawans, H. L., ed.), pp. 185–213. 1976.

  • Caraceni, T., Panerai, A. E., Parati, E. A., Cocchi, D., M:üler, E. E. Altered growth hormone and prolactin responses to dopaminergic stimulation in Huntington's chorea. J. Clin. Endocrinol. Metab.44, 870–875 (1977).

    Google Scholar 

  • Cavagnini, F., Panerai, A. E., Valentini, F., Bulgheroni, P., Peracchi, M., Pinto, M. Inhibition of ACTH response to oral and intravenous metyrapone by antiserotoninergic treatment in man. J. Clin. Endocrinol. Metab.41, 143–148 (1975).

    Google Scholar 

  • Chadwich, O., Reynolds, E. H., Marsden, C. D. Relief of action myoclonus by 5-hydroxytryptophan. Lancet2, 111–112 (1974).

    Google Scholar 

  • Chen, H. J., Meites, J. Effects of biogenic amines and TRH on release of prolactin and TSH in the rat. Endocrinology96, 10–14 (1975).

    Google Scholar 

  • Daughaday, W. H. The Adenohypophysis. In: Textbook of Endocrinology (Williams, R. H., ed.), pp. 31–79. Philadelphia: W. B. Saunders Co. 1974.

    Google Scholar 

  • del Pozo, E., Lancranjan, I. Clinical use of drugs modifying the release of anterior pituitary hormones. In: Frontiers in Neuroendocrinology, Vol. 5 (Ganong, W., Martini, L., eds.), pp. 207–247. New York: Raven Press. 1978.

    Google Scholar 

  • Enna, S. J., Stern, L. Z., Wastek, J., Yamamura, H. I. Neurobiology and pharmacology of Huntington's disease. Life Sci.20, 205–212 (1977).

    Google Scholar 

  • Frantz, A., Kleinberg, D., Noel, G. Studies on prolactin in man. Recent Prog. Horm. Res.28, 527–590 (1972).

    Google Scholar 

  • Fuller, R. W. Drugs influencing serotoninergic neurotransmission. In: Neuroactive Drugs in Endocrinology: Physiologic, Diagnostic and Therapeutic Applications (Müller, E. E., ed.), pp. 123–135. Amsterdam: Elsevier/North-Holland. 1980.

    Google Scholar 

  • Fuxe, K., Jonsson, G. Serotonin. New Vistas (Costa, E., Gessa, G. L., Sandler, M., eds.), pp. 1–12. New York: Raven Press. 1974.

    Google Scholar 

  • Gallo, R. V., Möberg, G. P. Serotonin mediated inhibition of episodic luteinizing hormone release during electrical stimulation of the arcuate nucleus in ovariectomized rats. Endocrinology100, 945–954 (1977).

    Google Scholar 

  • Grabowska, M., Kiewicz, A., Michaluk, J. A possible interaction of quipazine with central dopamine structures. J. Pharm. Pharmacol.26, 74–76 (1974).

    Google Scholar 

  • Hamon, M., Bourgoin, S., Enjalbert, A., Bockaert, J., Hery, F., Ternaux, J. P., Glowinski, J. The effects of quipazine on 5-HT metabolism in the rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol.294, 99–108 (1976).

    Google Scholar 

  • Handwerger, S., Plonk, J. W., Lebovitz, H. E., Bivens, C. H., Feldman, J. M. Failure of 5-hydroxytryptophan to stimulate prolactin and growth hormone secretion in man. Hormone Metab. Res.7, 214–217 (1975).

    Google Scholar 

  • Hong, E., Sancilio, F. L., Vargas, R., Pardo, E. G. Similarities between the pharmacological actions of quipazine and serotonin. Europ. J. Pharmacol.6, 274–280 (1969).

    Google Scholar 

  • Imura, H., Nakai, Y., Yoshimi, T. Effect of 5-hydroxytryptophan on growth hormone and ACTH release in man. J. Clin. Endocrinol. Metab.36, 204–206 (1973).

    Google Scholar 

  • Jordan, D., Poncet, C., Mornex, R., Ponsin, G. Participation of serotonin in thyrotropin release. I. Evidence for the action of serotonin on thyrotropin releasing hormone release. Endocrinology103, 414–419 (1978).

    Google Scholar 

  • Kamberi, I. A., Mical, R. S., Porter, J. C. Effect of anterior pituitary perfusion and intraventricular injection of catecholamines and indoleamines on LH release. Endocrinology87, 1–12 (1970).

    Google Scholar 

  • Kamberi, I. A., Mical, R. S., Porter, J. C. Effect of melatonin and serotonin on the release of FSH and prolactin. Endocrinology88, 1288–1293 (1971).

    Google Scholar 

  • Kordon, C., Blake, C. A., Terkel, J., Sawyer, C. H. Participation of the 5-HT-containing neurons in the suckling-induced rise in plasma prolactin levels in lactating rats. Neuroendocrinology13, 213–233 (1973/74).

    Google Scholar 

  • Krieger, H. P., Krieger, D. T. Chemical stimulation of the brain: effect on adrenal corticoid release. Am. J. Physiol.218, 1632–1641 (1970).

    Google Scholar 

  • Lancrajan, I., delPozo, E., Picciolini, E., D'Antona, N., Genazzani, A. Effect of two serotonin antagonists on prolactin release induced by breast stimulation in post-partum women. Hormone Res.10, 14–19 (1979).

    Google Scholar 

  • Locatelli, V., Cocchi, D., Panerai, A. E., Gil-Ad, I., Mantegazza, P., Secchi, C., Müller, E. E. Drug-induced changes of brain serotoninergic tone and insulin-induced growth hormone release in the dog. Neuroendocrinology25, 84–104 (1978).

    Google Scholar 

  • Malick, J. B., Doren, E., Barnett, A. Quipazine-induced head-twitch in mice. Pharmac. Biochem. Behav.6, 325–329 (1977).

    Google Scholar 

  • Marchlewska-Koj, A., Krulich, L. The role of central monoamines in the stress-induced prolactin release in the rat. Fed. Proc. Fed. Am. Soc. Exp. Biol.34, 252 (1975).

    Google Scholar 

  • McCann, S., Krulich, L., Ojeda, S. R., Negro-Vilar, A., Vijayan, E. Neurotransmitters in the control of anterior pituitary function. In: Central Regulation of the Endocrine Systems (Fuxe, K., Hökfelt, T., Luft, R., eds.), pp. 329–347. New York-London: Plenum Press. 1979.

    Google Scholar 

  • McIndoe, J. H., Turkington, R. W. Stimulation of human prolactin secretion by intravenous infusion of 1-tryptophan. J. Clin. Invest.52, 1972–1978 (1973).

    Google Scholar 

  • McLeod, R. M., Login, I. S. Regulation of prolactin secretion through dopamine, serotonin and the cerebrospinal fluid. In: Nonstriatal Dopaminergic Neurons (Costa, E., Gessa, G. L., eds.), pp. 147–157. New York: Raven Press. 1977.

    Google Scholar 

  • Meltzer, H. Y., Fang, V. S., Paul, S. M., Kaluskar, R. Effect of quipazine on rat plasma prolactin levels. Life Sci.19, 1075–1078 (1976).

    Google Scholar 

  • Mess, B., Peter, L. Effect of intracerebral serotonin administration on pituitary thyroid function. Endocrinol. Exp.9, 105–113 (1975).

    Google Scholar 

  • Midgley, A. G., jr. Radioimmunoassay method for human chorionic gonadotropin and human LH. Endocrinology79, 10–18 (1966).

    Google Scholar 

  • Midgley, A. G., jr. Radioimmunoassay for human follicle-stimulating hormone. J. Clin. Endocrinol. Metab.27, 295–299 (1967).

    Google Scholar 

  • Müller, E. E., Nisticò, G., Scapagnini, U. Neurotransmitters and Anterior Pituitary Function. New York: Academic Press. 1978.

    Google Scholar 

  • Müller, E. E., Brambilla, F., Cavagnini, F., Peracchi, M., Panerai, A. E. Slight effect of 1-tryptophan on GH release in normal human subjects. J. Clin. Endocr. Metab.39, 1–6 (1974).

    Google Scholar 

  • Müller, E. E., Udeschini, G., Secchi, C., Zambotti, F., Panerai, A. E., Vicentini, L., Cocola, F., Mantegazza, P. Inhibitory role of the serotoninergic system on hypoglycaemia-induced growth hormone release in the dog. Acta Endocrinol. (Kbh.)82, 71–91 (1976).

    Google Scholar 

  • Müller, E. E., Parati, E. A., Panerai, A. E., Cocchi, D., Caraceni, T. Growth hormone hyperresponsiveness to dopaminergic stimulation in Huntington's chorea. Neuroendocrinology28, 313–319 (1979).

    Google Scholar 

  • Mulloy, A. L., Möberg, G. B. Effects of p-chlorophenylalanine and raphe lesions on diurnal prolactin release in the rat. Fed. Proc. Fed. Am. Soc. Exp. Biol.34, 251 (1975).

    Google Scholar 

  • Neill, J. D. Effect of “stress” on serum prolactin and luteinizing hormone levels during the estrous cycle of the rat. Endocrinology87, 1192–1197 (1970).

    Google Scholar 

  • Odell, W. D., Wilberg, J. F., Utiger, R. D. Studies of thyrotropin physiology by means of radioimmunoassay. Recent Prog. Horm. Res.23, 47–85 (1967).

    Google Scholar 

  • Plonk, J. W., Bivens, C. H., Feldman, J. M. Inhibition of hypoglycemiainduced cortisol secretion by the serotonin antagonist cyproheptadne. J. Clin. Endocrinol. Metab.38, 836–840 (1974).

    Google Scholar 

  • Plonk, J., Feldman, J. M. Modification of adrenal function by the antiserotonin agent cyproheptadine. J. Clin. Endocrinol. Metab.42, 291–295 (1976).

    Google Scholar 

  • Rodriguez, R., Rojas-Ramirez, A., Drucker-Colin, R. R. Serotonin like actions of quipazine on the central nervous system. Europ. J. Pharmacol.24, 164–171 (1973).

    Google Scholar 

  • Ruch, W., Mixter, R. C., Russell, R. M., Garcia, G. F., Gale, C. C. Aminergic and thermoregulatory mechanisms in hypothalamic regulation of growth hormone in cats. Am. J. Physiol.233, E61-E69 (1977).

    Google Scholar 

  • Schalch, S., Parker, M. A sensitive double-antibody immunoassay for human growth hormone in plasma. Nature203, 1141–1142 (1964).

    Google Scholar 

  • Schalch, S., Reichlin, S. Stress and growth hormone release. In: Growth Hormone (Pecile, A., Müller, E. E., eds.), pp. 211–225. Amsterdam: Excerpta Medica. 1968.

    Google Scholar 

  • Smythe, G. A., Compton, P. S., Lazarus, L. Serotoninergic control of human growth hormone secretion: the action of 1-dopa and 2-bromo-α-ergocryptine. In: Growth Hormone and Related Peptides (Pecile, A., Müller, E. E., eds.), pp. 222–235. Amsterdam: Excerpta Medica. 1976.

    Google Scholar 

  • Toivola, P. T. K., Gale, C. C. Stimulation of growth hormone release by microinjection of norepinephrine into hypothalamus of baboons. Endocrinology90, 895–902 (1972).

    Google Scholar 

  • Tuomisto, J., Ranta, T., Mannisto, P., Saarinen, A., Leppaluoto, J. Neurotransmitter control of thyrotropin secretion in the rat. Europ. J. Pharmacol.30, 221–229 (1975).

    Google Scholar 

  • Van Loon, G. R. Brain catecholamines and ACTH secretion. In: Frontiers in Neuroendocrinology, Vol. 3 (Ganong, W. F., Martini, L., eds.), pp. 209–248. New York: Oxford University Press. 1973.

    Google Scholar 

  • Van Woert, M. H., Rosenbaum, D., Howieson, J., Bowers, M. B., jr. Longterm therapy of myoclonus and other neurologic disorders with L-5-hydroxytryptophan and carbidopa. N. Engl. J. Med.296, 70–74 (1977).

    Google Scholar 

  • Vermes, J., Molnar, D., Teledgy, G. The effect of hypothalamic serotonin on compensatory adrenal function. Acta Physiol. Acad. Sci. Hung.43, 27–32 (1973).

    Google Scholar 

  • Vjayan, E., Krulich, L., McCann, S. M. Stimulation of growth hormone release by intraventricular administration of 5-HT or quipazine in unanesthetized male rats. Proc. Soc. Exp. Biol. Med.159, 210–211 (1978).

    Google Scholar 

  • Wiebe, R. H., Handwerger, S., Hammond, C. B. Failure of L-tryptophan to stimulate prolactin secretion in man. J. Clin. Endocrinol. Metab.45, 1310–1312 (1977).

    Google Scholar 

  • Woolf, P. D., Lee, L. Effect of the serotonin precursor, tryptophan, on pituitary hormone secretion. J. Clin. Endocrinol. Metab.45, 123–133 (1977).

    Google Scholar 

Download references

Author information

Author notes

  1. E. E. Müllet

    Present address: Department of Pharmacology, University of Milan, Italy

Authors and Affiliations

  1. Istituto Neurologico C. Besta, Milan

    E. A. Parati, P. Zanardi, D. Cocchi, T. Caraceni & E. E. Müllet

  2. Department of Pharmacology, University of Milan, Italy

    D. Cocchi

  3. Institute of Pharmacology and Pharmacognosy, University of Cagliari, Italy

    E. E. Müllet

Authors
  1. E. A. Parati
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Zanardi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. Cocchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T. Caraceni
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. E. Müllet
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Supported by Hereditary Disease Foundation, Beverly Hills, California, U.S.A.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Parati, E.A., Zanardi, P., Cocchi, D. et al. Neuroendocrine effects of quipazine in man in health state or with neurological disorders. J. Neural Transmission 47, 273–297 (1980). https://doi.org/10.1007/BF01247322

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01247322

Keywords

Search

Navigation